Gapping up
In reaction to earnings/guidance:
- EXPO +4.5%, KMB +4.4%, LII +4.2%, HAL +2.8%, LECO +0.5%
M&A news:
- KEYW +43.3% (to be acquired by Jacobs (JEC) for $11.25/share in cash)
- MDSO +9% (Dassault Systemes (DASTY) said to be studying a possible acquisition of Medidata, according to Bloomberg)
Select oil/gas related names showing early weakness:
- CHK +4.1%, DNR +3.2%, WLL +2.3%, MUR +2.3%, RIG +2.1%, MRO +2%, ESV +1.6%, NBL +1.6%, SWN +1.4%, DVN +1.3%, APA +1.3%, SM +1.3%, COP +1.2%, XOM +1.1%, OXY +0.9%, .
Other news:
- AKRX +14.8% (receives FDA approval for ANDA for Fluticasone Propionate Nasal Spray USP, 50 mcg per spray; receives ANDA approval from FDA for Loteprednol Etabonate Ophthalmic Suspension, 0.5%)
- PYX +3.7% (being attributed to Morgan Stanley disclosure of 5.1% passive stake)
- RCII +3.5% (agrees in principle to settle all litigation with Vintage Capital Management and B. Riley Financial)
- AMRS +3% (discloses terms of Securities Purchase Agreement with Foris Ventures, issued 6,732,369 shares of Common Stock at a price of $2.87 per share and a warrant to purchase 5,424,804 shares of Common Stock at an exercise price of $2.87 per share)
- BBBY +1.7% (announces transformation of Board and additional governance enhancements -- forming business transformation and strategy review committee)
- FAST +1.1% (approved a two-for-one stock split of the outstanding common stock)
Analyst comments:
- LRCX +1.1% (upgraded to Buy at B. Riley FBR)